Plug-assisted retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage

Min Yung Chang, ManDeuk Kim, Taehwan Kim, Wonseon Shin, Minwoo Shin, Gyoung Min Kim, Jong Yun Won, Sung Il Park, Do Yun Lee

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: To evaluate the feasibility, safety, and clinical outcomes of plug-assisted retrograde transvenous obliteration (PARTO) to treat gastric variceal hemorrhage in patients with portal hypertension. Materials and Methods: From May 2012 to June 2014, 19 patients (11 men and 8 women, median age; 61, with history of gastric variceal hemorrhage; 17, active bleeding; 2) who underwent PARTO using a vascular plug and a gelfoam pledget were retrospectively analyzed. Clinical and laboratory data were examined to evaluate primary (technical and clinical success, complications) and secondary (worsening of esophageal varix [EV], change in liver function) end points. Median follow-up duration was 11 months, from 6.5 to 18 months. The Wilcoxon signed-rank test was used to compare laboratory data before and after the procedure. Results: Technical success (complete occlusion of the efferent shunt and complete filling of gastric varix [GV] with a gelfoam slurry) was achieved in 18 of 19 (94.7%) patients. The embolic materials could not reach the GV in 1 patient who had endoscopic glue injection before our procedure. The clinical success rate (no recurrence of gastric variceal bleeding) was the same because the technically failed patient showed recurrent bleeding later. Acute complications included fever (n = 2), fever and hypotension (n = 2; one diagnosed adrenal insufficiency), and transient microscopic hematuria (n = 3). Ten patients underwent follow-up endoscopy; all exhibited GV improvement, except 2 without endoscopic change. Five patients exhibited aggravated EV, and 2 of them had a bleeding event. Laboratory findings were significantly improved after PARTO. Conclusion: PARTO is technically feasible, safe, and effective for gastric variceal hemorrhage in patients with portal hypertension.

Original languageEnglish
Pages (from-to)230-238
Number of pages9
JournalKorean journal of radiology
Volume17
Issue number2
DOIs
Publication statusPublished - 2016 Mar 1

Fingerprint

Stomach
Esophageal and Gastric Varices
Hemorrhage
Absorbable Gelatin Sponge
Portal Hypertension
Therapeutics
Fever
Adrenal Insufficiency
Hematuria
Nonparametric Statistics
Adhesives
Hypotension
Endoscopy
Blood Vessels
Safety
Recurrence
Injections
Liver

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Chang, Min Yung ; Kim, ManDeuk ; Kim, Taehwan ; Shin, Wonseon ; Shin, Minwoo ; Kim, Gyoung Min ; Won, Jong Yun ; Park, Sung Il ; Lee, Do Yun. / Plug-assisted retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage. In: Korean journal of radiology. 2016 ; Vol. 17, No. 2. pp. 230-238.
@article{2a6307c8dbfc43a28359c83e1923ab71,
title = "Plug-assisted retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage",
abstract = "Objective: To evaluate the feasibility, safety, and clinical outcomes of plug-assisted retrograde transvenous obliteration (PARTO) to treat gastric variceal hemorrhage in patients with portal hypertension. Materials and Methods: From May 2012 to June 2014, 19 patients (11 men and 8 women, median age; 61, with history of gastric variceal hemorrhage; 17, active bleeding; 2) who underwent PARTO using a vascular plug and a gelfoam pledget were retrospectively analyzed. Clinical and laboratory data were examined to evaluate primary (technical and clinical success, complications) and secondary (worsening of esophageal varix [EV], change in liver function) end points. Median follow-up duration was 11 months, from 6.5 to 18 months. The Wilcoxon signed-rank test was used to compare laboratory data before and after the procedure. Results: Technical success (complete occlusion of the efferent shunt and complete filling of gastric varix [GV] with a gelfoam slurry) was achieved in 18 of 19 (94.7{\%}) patients. The embolic materials could not reach the GV in 1 patient who had endoscopic glue injection before our procedure. The clinical success rate (no recurrence of gastric variceal bleeding) was the same because the technically failed patient showed recurrent bleeding later. Acute complications included fever (n = 2), fever and hypotension (n = 2; one diagnosed adrenal insufficiency), and transient microscopic hematuria (n = 3). Ten patients underwent follow-up endoscopy; all exhibited GV improvement, except 2 without endoscopic change. Five patients exhibited aggravated EV, and 2 of them had a bleeding event. Laboratory findings were significantly improved after PARTO. Conclusion: PARTO is technically feasible, safe, and effective for gastric variceal hemorrhage in patients with portal hypertension.",
author = "Chang, {Min Yung} and ManDeuk Kim and Taehwan Kim and Wonseon Shin and Minwoo Shin and Kim, {Gyoung Min} and Won, {Jong Yun} and Park, {Sung Il} and Lee, {Do Yun}",
year = "2016",
month = "3",
day = "1",
doi = "10.3348/kjr.2016.17.2.230",
language = "English",
volume = "17",
pages = "230--238",
journal = "Korean Journal of Radiology",
issn = "1229-6929",
publisher = "Korean Radiological Society",
number = "2",

}

Plug-assisted retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage. / Chang, Min Yung; Kim, ManDeuk; Kim, Taehwan; Shin, Wonseon; Shin, Minwoo; Kim, Gyoung Min; Won, Jong Yun; Park, Sung Il; Lee, Do Yun.

In: Korean journal of radiology, Vol. 17, No. 2, 01.03.2016, p. 230-238.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Plug-assisted retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage

AU - Chang, Min Yung

AU - Kim, ManDeuk

AU - Kim, Taehwan

AU - Shin, Wonseon

AU - Shin, Minwoo

AU - Kim, Gyoung Min

AU - Won, Jong Yun

AU - Park, Sung Il

AU - Lee, Do Yun

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Objective: To evaluate the feasibility, safety, and clinical outcomes of plug-assisted retrograde transvenous obliteration (PARTO) to treat gastric variceal hemorrhage in patients with portal hypertension. Materials and Methods: From May 2012 to June 2014, 19 patients (11 men and 8 women, median age; 61, with history of gastric variceal hemorrhage; 17, active bleeding; 2) who underwent PARTO using a vascular plug and a gelfoam pledget were retrospectively analyzed. Clinical and laboratory data were examined to evaluate primary (technical and clinical success, complications) and secondary (worsening of esophageal varix [EV], change in liver function) end points. Median follow-up duration was 11 months, from 6.5 to 18 months. The Wilcoxon signed-rank test was used to compare laboratory data before and after the procedure. Results: Technical success (complete occlusion of the efferent shunt and complete filling of gastric varix [GV] with a gelfoam slurry) was achieved in 18 of 19 (94.7%) patients. The embolic materials could not reach the GV in 1 patient who had endoscopic glue injection before our procedure. The clinical success rate (no recurrence of gastric variceal bleeding) was the same because the technically failed patient showed recurrent bleeding later. Acute complications included fever (n = 2), fever and hypotension (n = 2; one diagnosed adrenal insufficiency), and transient microscopic hematuria (n = 3). Ten patients underwent follow-up endoscopy; all exhibited GV improvement, except 2 without endoscopic change. Five patients exhibited aggravated EV, and 2 of them had a bleeding event. Laboratory findings were significantly improved after PARTO. Conclusion: PARTO is technically feasible, safe, and effective for gastric variceal hemorrhage in patients with portal hypertension.

AB - Objective: To evaluate the feasibility, safety, and clinical outcomes of plug-assisted retrograde transvenous obliteration (PARTO) to treat gastric variceal hemorrhage in patients with portal hypertension. Materials and Methods: From May 2012 to June 2014, 19 patients (11 men and 8 women, median age; 61, with history of gastric variceal hemorrhage; 17, active bleeding; 2) who underwent PARTO using a vascular plug and a gelfoam pledget were retrospectively analyzed. Clinical and laboratory data were examined to evaluate primary (technical and clinical success, complications) and secondary (worsening of esophageal varix [EV], change in liver function) end points. Median follow-up duration was 11 months, from 6.5 to 18 months. The Wilcoxon signed-rank test was used to compare laboratory data before and after the procedure. Results: Technical success (complete occlusion of the efferent shunt and complete filling of gastric varix [GV] with a gelfoam slurry) was achieved in 18 of 19 (94.7%) patients. The embolic materials could not reach the GV in 1 patient who had endoscopic glue injection before our procedure. The clinical success rate (no recurrence of gastric variceal bleeding) was the same because the technically failed patient showed recurrent bleeding later. Acute complications included fever (n = 2), fever and hypotension (n = 2; one diagnosed adrenal insufficiency), and transient microscopic hematuria (n = 3). Ten patients underwent follow-up endoscopy; all exhibited GV improvement, except 2 without endoscopic change. Five patients exhibited aggravated EV, and 2 of them had a bleeding event. Laboratory findings were significantly improved after PARTO. Conclusion: PARTO is technically feasible, safe, and effective for gastric variceal hemorrhage in patients with portal hypertension.

UR - http://www.scopus.com/inward/record.url?scp=84960131263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960131263&partnerID=8YFLogxK

U2 - 10.3348/kjr.2016.17.2.230

DO - 10.3348/kjr.2016.17.2.230

M3 - Article

VL - 17

SP - 230

EP - 238

JO - Korean Journal of Radiology

JF - Korean Journal of Radiology

SN - 1229-6929

IS - 2

ER -